Driehaus Capital WGSWW Position
Active5-Fund ConvergenceDriehaus Capital trimmed their position in GeneDx Holdings Corp. (WGSWW) in Q4 2025, holding $51.4M worth of shares across 395,323 shares.
The position was first reported in Q2 2024 and has been tracked across 7 quarterly 13F filings.
WGSWW is a convergence signal: 5 specialist biotech funds hold this stock, suggesting high institutional conviction.
About GeneDx Holdings Corp.
GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut.
Full company profile →Driehaus Capital WGSWW Position History
Frequently Asked Questions
Does Driehaus Capital own WGSWW?
Yes. As of Q4 2025, Driehaus Capital holds 395,323 shares of GeneDx Holdings Corp. (WGSWW) valued at $51.4M. This data comes from their SEC 13F filing.
How many hedge funds own WGSWW?
5 specialist biotech hedge funds currently hold WGSWW, including Casdin Capital, Deerfield Management, Tang Capital Management and 1 more. When 3 or more specialist funds hold the same stock, BiotechEdge flags it as a convergence signal.
When did Driehaus Capital first buy WGSWW?
Driehaus Capital's position in WGSWW was first reported in Q2 2024. 13F filings are reported with a 45-day delay, so the actual purchase may have occurred earlier in the quarter.
Is Driehaus Capital's WGSWW position increasing or decreasing?
Driehaus Capital trimmed their WGSWW position in the most recent quarter, reducing by 14,707 shares.
Get the weekly biotech signal briefing
Fund moves, convergence shifts, insider buys, and catalyst alerts — delivered free every Monday.
WGSWWCompany Page →
All fund holders, insider trades, catalysts, and cash runway
Driehaus CapitalPortfolio →
Full 13F holdings, sector breakdown, and top movers
Drill into any signal
Fund Convergence
See which stocks multiple specialist funds are buying at once
Catalyst Calendar
Every PDUFA date, Phase 3 readout, and AdCom in one view
Insider Trading
When executives buy their own stock — the strongest bullish signal
Cash Runway
Which biotechs are running low on cash and face dilution risk
Short Squeeze
High short interest + fund buying + upcoming catalyst = squeeze setup
Signal Rankings
Every signal in one composite score — ranked by conviction
Biotech Movers
Stocks with the most signal activity right now across all signals
13F Changes
What top biotech funds bought and sold in the latest 13F filing
Want AI context on every signal? Start free trial →